Next Article in Journal
Kaumoebavirus, a New Virus That Clusters with Faustoviruses and Asfarviridae
Previous Article in Journal
Antiviral Screening of Multiple Compounds against Ebola Virus
Article Menu

Export Article

Open AccessReview
Viruses 2016, 8(11), 279; doi:10.3390/v8110279

Rabies Control and Treatment: From Prophylaxis to Strategies with Curative Potential

Shenzhen Weiguang Biological Products Co., Ltd., Shenzhen 518107, China
*
Author to whom correspondence should be addressed.
Academic Editor: Alexander Ploss
Received: 17 September 2016 / Revised: 17 October 2016 / Accepted: 20 October 2016 / Published: 28 October 2016
(This article belongs to the Section Antivirals & Vaccines)
View Full-Text   |   Download PDF [283 KB, uploaded 28 October 2016]

Abstract

Rabies is an acute, fatal, neurological disease that affects almost all kinds of mammals. Vaccination (using an inactivated rabies vaccine), combined with administration of rabies immune globulin, is the only approved, effective method for post-exposure prophylaxis against rabies in humans. In the search for novel rabies control and treatment strategies, live-attenuated viruses have recently emerged as a practical and promising approach for immunizing and controlling rabies. Unlike the conventional, inactivated rabies vaccine, live-attenuated viruses are genetically modified viruses that are able to replicate in an inoculated recipient without causing adverse effects, while still eliciting robust and effective immune responses against rabies virus infection. A number of viruses with an intrinsic capacity that could be used as putative candidates for live-attenuated rabies vaccine have been intensively evaluated for therapeutic purposes. Additional novel strategies, such as a monoclonal antibody-based approach, nucleic acid-based vaccines, or small interfering RNAs (siRNAs) interfering with virus replication, could further add to the arena of strategies to combat rabies. In this review, we highlight current advances in rabies therapy and discuss the role that they might have in the future of rabies treatment. Given the pronounced and complex impact of rabies on a patient, a combination of these novel modalities has the potential to achieve maximal anti-rabies efficacy, or may even have promising curative effects in the future. However, several hurdles regarding clinical safety considerations and public awareness should be overcome before these approaches can ultimately become clinically relevant therapies. View Full-Text
Keywords: rabies; rabies vaccine; live-attenuated viruses; monoclonal antibody; nucleic acid-based vaccine; anti-viral therapy rabies; rabies vaccine; live-attenuated viruses; monoclonal antibody; nucleic acid-based vaccine; anti-viral therapy
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Zhu, S.; Guo, C. Rabies Control and Treatment: From Prophylaxis to Strategies with Curative Potential. Viruses 2016, 8, 279.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top